Acutus Medical Inc. (AFIB): Price and Financial Metrics

Acutus Medical Inc. (AFIB): $8.58

-0.48 (-5.30%)

POWR Rating

Component Grades














  • Growth is the dimension where AFIB ranks best; there it ranks ahead of 74.65% of US stocks.
  • The strongest trend for AFIB is in Quality, which has been heading down over the past 48 weeks.
  • AFIB's current lowest rank is in the Quality metric (where it is better than 1.99% of US stocks).

AFIB Stock Summary

  • Acutus Medical Inc's stock had its IPO on August 6, 2020, making it an older stock than merely 0.66% of US equities in our set.
  • In terms of volatility of its share price, AFIB is more volatile than 93.42% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AFIB comes in at -53.37% -- higher than that of only 5.07% of stocks in our set.
  • Stocks that are quantitatively similar to AFIB, based on their financial statements, market capitalization, and price volatility, are MYOV, VIVE, NSTG, PSTG, and LPSN.
  • Visit AFIB's SEC page to see the company's official filings. To visit the company's web site, go to

AFIB Valuation Summary

  • AFIB's EV/EBIT ratio is -4.3; this is 114.68% lower than that of the median Healthcare stock.
  • AFIB's price/sales ratio has moved down 130.4 over the prior 13 months.
  • Over the past 13 months, AFIB's price/sales ratio has gone down 130.4.

Below are key valuation metrics over time for AFIB.

Stock Date P/S P/B P/E EV/EBIT
AFIB 2021-08-31 31.5 5.8 -3.7 -4.3
AFIB 2021-08-30 31.9 5.9 -3.8 -4.3
AFIB 2021-08-27 32.9 6.1 -3.9 -4.4
AFIB 2021-08-26 31.9 5.9 -3.8 -4.3
AFIB 2021-08-25 32.5 6.0 -3.8 -4.4
AFIB 2021-08-24 32.4 6.0 -3.8 -4.4

AFIB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AFIB has a Quality Grade of F, ranking ahead of 2.17% of graded US stocks.
  • AFIB's asset turnover comes in at 0.079 -- ranking 156th of 183 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows AFIB's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.079 -0.743 -0.714
2021-03-31 0.066 -0.876 -0.809
2020-12-31 0.060 -0.877 -0.878

AFIB Price Target

For more insight on analysts targets of AFIB, see our AFIB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $20.67 Average Broker Recommendation 1.6 (Moderate Buy)

AFIB Stock Price Chart Interactive Chart >

Price chart for AFIB

AFIB Price/Volume Stats

Current price $8.58 52-week high $34.35
Prev. close $9.06 52-week low $8.57
Day low $8.57 Volume 258,300
Day high $9.03 Avg. volume 335,061
50-day MA $13.02 Dividend yield N/A
200-day MA $17.89 Market Cap 296.94M

Acutus Medical Inc. (AFIB) Company Bio

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists. Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, California. Its products are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.

AFIB Latest News Stream

Event/Time News Detail
Loading, please wait...

AFIB Latest Social Stream

Loading social stream, please wait...

View Full AFIB Social Stream

Latest AFIB News From Around the Web

Below are the latest news stories about Acutus Medical Inc that investors may wish to consider to help them evaluate AFIB as an investment opportunity.

Acutus Medical, Inc. (AFIB) Q2 2021 Earnings Call Transcript

AFIB earnings call for the period ending June 30, 2021.

Yahoo | August 13, 2021

Acutus Medical Inc Registered Shs hosts conference call for investors

The company, Acutus Medical Inc Registered Shs, is set to host investors and clients on a conference call on 8/12/2021 9:09:34 PM. The call comes after the company''s earnings, which are set to be announced on 8/12/2021.Investors, or members of the public who wish to dial in, can join the call by visiting

Business Insider Markets | August 12, 2021

Acutus Medical Reports Second Quarter 2021 Financial Results

CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2021.

Intrado Digital Media | August 12, 2021

Acutus Medical Appoints Niamh Pellegrini to Board of Directors

CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the appointment of Niamh Pellegrini to the Company''s Board of Directors, effective August 10, 2021.

Intrado Digital Media | August 12, 2021

Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 11.00% and 1.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 12, 2021

Read More 'AFIB' Stories Here

AFIB Price Returns

1-mo -33.69%
3-mo -51.42%
6-mo -34.20%
1-year -71.17%
3-year N/A
5-year N/A
YTD -70.22%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8378 seconds.